Skip to main content
PMC home page
Case Reports in Oncological Medicine logoLink to Case Reports in Oncological Medicine
. 2019 Oct 28;2019:3868790. doi: 10.1155/2019/3868790

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”

Vidhya Karivedu 1,✉, Ihab Eldessouki 1, Zelia Correa 2, Ahmad Taftaf 1, Zheng Zhu 3, Abouelmagd Makramalla 4, Nagla Abdel Karim 5
PMCID: PMC6854979  PMID: 31772797

In the article titled “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience” [1], Dr. Zelia Correa was missing from the authors' list. Dr. Zelia Correa commented on the article and referred the patient population in the study. The corrected authors' list and affiliations are shown above.

References

  • 1.Karivedu V., Eldessouki I., Taftaf A., Zhu Z., Makramalla A., Karim N. A. Nivolumab and ipilimumab in the treatment of metastatic uveal melanoma: a single-center experience. Case Reports in Oncological Medicine. 2019;2019:8. doi: 10.1155/2019/3560640.3560640 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Case Reports in Oncological Medicine are provided here courtesy of Wiley

RESOURCES